Hydroxychloroquine in ANCA Vasculitis Evaluation
Conditions:   ANCA Associated Vasculitis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Wegener Granulomatosis Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo Sponsors:   Guy's and St Thomas' NHS Foundation Trust;   Medical Research Council Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2020 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Journey of Patients With Vasculitis From First Symptom to Diagnosis
Conditions:   Vasculitis;   Systemic Vasculitis;   Behcet's Disease;   CNS Vasculitis;   Cryoglobulinemic Vasculitis;   Eosinophilic Granulomatous Vasculitis;   Temporal Arteritis;   Giant Cell Arteritis;   Granulomatosis With Polyangiitis;   Wegener Granulomatosis;   Henoch Schonlein  Purpura;   IgA Vasculitis;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu Arteritis;   Urticarial Vasculitis Intervention:   Other: Online&nbs...
Source: ClinicalTrials.gov - January 25, 2018 Category: Research Source Type: clinical trials